Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, April 19, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
FDA Approves Neurelis’ VALTOCO Nasal Spray for Seizure Clusters in Children as Young as 2
Life Sciences Times
-
April 16, 2025
Pharma
MindMed Doses First Patient in Phase 3 Trial of LSD-Based Therapy for Major Depressive Disorder
Life Sciences Times
-
April 15, 2025
Pharma
Scipher Medicine and Kythera Labs Join Forces to Advance Precision Treatment for Autoimmune Diseases
Life Sciences Times
-
April 15, 2025
Pharma
Pfizer Halts Development of Oral Weight Loss Drug Danuglipron
Life Sciences Times
-
April 14, 2025
Pharma
Pheast Therapeutics Begins Phase 1 Trial of Macrophage Checkpoint Inhibitor PHST001 for Advanced Solid Tumors
Life Sciences Times
-
April 14, 2025
Pharma
University of Maryland School of Pharmacy Taps Komodo Health Platform To Power Real-World Evidence Research
Life Sciences Times
-
September 21, 2022
0
Pharma
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Versions of TAZORAC® (tazarotene) gel, 0.05% and 0.1%, with 180 days Competitive Generic Therapy...
Life Sciences Times
-
September 20, 2022
0
Pharma
Alnylam and Regeneron Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers
Life Sciences Times
-
September 15, 2022
0
Pharma
Inversago Pharma receives IND clearance for Phase 2 trial of INV-202 in Diabetic Kidney Disease
Life Sciences Times
-
September 15, 2022
0
Pharma
Integrated DNA Technologies Expands Customization Options for Alt-R™ Custom CRISPR gRNA Libraries for Drug Discovery
Life Sciences Times
-
September 14, 2022
0
Pharma
Octapharma USA to Present Clinical Overview of Dermatomyositis During The Myositis Association’s Annual Conference
Life Sciences Times
-
September 7, 2022
0
Pharma
IMFINZI® (durvalumab) Plus Chemotherapy Approved in the US as the First Immunotherapy Regimen for Patients with Advanced Biliary Tract Cancer
Life Sciences Times
-
September 6, 2022
0
Pharma
OKYO Pharma Plans Q4 2022 IND Filing of OK-101 to treat Dry Eye Disease with Subsequent Phase 2 Initiation Alongside Peptide Manufacturing Partner, AmbioPharm
Life Sciences Times
-
August 30, 2022
0
Pharma
New data show FARXIGA significantly lowers the risk of cardiovascular death in patients with heart failure
Life Sciences Times
-
August 29, 2022
0
Pharma
The Polypill Reduces Cardiovascular Mortality by 33% in Patients Treated After Myocardial Infarction
Life Sciences Times
-
August 26, 2022
0
Pharma
Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate
Life Sciences Times
-
August 25, 2022
0
Pharma
Professional Golfer Aza Muñoz Returns to LPGA Tour with New Solution for Treating Her Hypothyroidism
Life Sciences Times
-
August 24, 2022
0
1
...
19
20
21
...
62
Page 20 of 62
Most Read
Alis Biosciences Launches Fund to Unlock $30 Billion in Trapped Capital from Struggling Biotech Firms
April 18, 2025
$2.25 Million Settlement Reached in Effexor XR® Class-Action Lawsuit Involving Teva Pharmaceuticals
April 18, 2025
Tempus Forms Advisory Board of Leading Physicians to Guide AI-Driven Precision Medicine
April 18, 2025
Beneath the biotech boom
April 17, 2025